You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 26, 2024

Claims for Patent: 5,308,763


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,308,763
Title: Method of making primary culture of olfactory neurons
Abstract:A method of producing primary cultures of olfactory neurons which are purified from sustentacular cells and basal cells. The neuronal cells demonstrate responsiveness to physiologic levels of odorants and express Olfactory Marker Protein (OMP). The steps required to obtain the primary cultures are: 1. providing olfactory epithelium of an animal; 2. dissociation of neuronal cells using enzymatic digestion; 3. filtering using a mesh filter having a pore size between 10 and 25 microns to separate cell aggregates; 4. removal of the cell aggregates; and 5. plating the dissociated neuronal cells in a nutrient medium containing D-valine, Nerve Growth Factor (NGF), and other significant ingredients to obtain a culture of olfactory neurons. In addition to OMP the neurons are capable of expressing vimentin, neuron-specific enolase but not expressing glial fibrillary acidic proteins, S-100 protein, keratin, or neurofilament protein.
Inventor(s): Ronnett; Gabriele V. (Baltimore, MD), Hester; Lynda (Towson, MD), Snyder; Solomon H. (Baltimore, MD)
Assignee: The Johns Hopkins University (Baltimore, MD)
Application Number:07/848,687
Patent Claims:1. A method of producing primary cultures of olfactory neurons substantially purified from sustentacular cells and basal cells, said neurons demonstrating responsiveness to physiologic levels of odorants, said neurons expressing vimentin, olfactory marker protein and neuron-specific enolase, said neurons not expressing glial fibrillary acidic protein, S-100 protein, keratin, or neurofilament protein, comprising the steps of:

providing olfactory epithelium of an animal;

enzymatically digesting the olfactory epithelium to dissociate neuronal cells of said olfactory epithelium;

passing said dissociated neuronal cells of said olfactory epithelium through a mesh filter having a pore size of between about 10 and 25 microns to separate cell aggregates which fail to pass through the mesh filter from said dissociated neuronal cells;

removing said cell aggregates from said dissociated neuronal cells;

plating said dissociated neuronal cells in a nutrient medium comprising D-valine, cytosine arabinoside, and NGG on a solid substrate to provide a primary culture of olfactory neurons substantially purified from sustentacular cells and basal cells, said neurons demonstrating responsiveness to physiologic levels of odorants, said neurons expressing vimentin, olfactory marker protein and neuron-specific enolase, said neurons not expressing glial fibrillary acidic protein, S-100 protein, keratin, or neurofilament protein.

2. The method of claim 1 wherein the animal is a neonate.

3. The method of claim 1 wherein the neuronal cells are dissociated by mechanical and enzymatic means.

4. The method of claim 3 wherein the mechanical means comprises trituration.

5. The method of claim 1 wherein the neuronal cells are dissociated with a mixture of hyaluronidase, DNAse, collagenase, and dispase.

6. The method of claim 1 wherein the mesh filter has a pore size of about 20 microns.

7. The method of claim 1 wherein the mesh filter has a pore size of about 10 microns.

8. The method of claim 1 wherein the solid substrate is coated with one or more matrix substances selected from the group consisting of: laminin, fibronectin, and matrigel.

9. The method of claim 1 wherein the animal is a rat.

10. The method of claim 1 wherein the enzymatic digestion employs one or more enzymes selected from the group consisting of: hyaluronidase, DNAse, collagenase, and dispase.

Details for Patent 5,308,763

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Bausch & Lomb Incorporated VITRASE hyaluronidase Injection 021640 05/05/2004 ⤷  Try a Trial 2011-10-01
Bausch & Lomb Incorporated VITRASE hyaluronidase Injection 021640 12/02/2004 ⤷  Try a Trial 2011-10-01
Amphastar Pharmaceuticals, Inc. AMPHADASE hyaluronidase Injection 021665 10/26/2004 ⤷  Try a Trial 2011-10-01
Akorn, Inc. HYDASE hyaluronidase Injection 021716 10/25/2005 ⤷  Try a Trial 2011-10-01
Smith & Nephew, Inc. SANTYL collagenase Ointment 101995 06/04/1965 ⤷  Try a Trial 2011-10-01
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.